Angiotensin-converting enzyme (ACE) inhibitor angioedema: The silent epidemic

American Journal of Cardiology

Volumn 109, Issue 5, 2012, Pages 774-775

  Roberts, James R ^a   Lee, Jena J ^a   Marthers, Deborah A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENAZEPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL;

ADULT; AGED; ANGIONEUROTIC EDEMA; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOTE; PRIORITY JOURNAL; SYMPTOM;

EID: 84863144408     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.11.014     Document Type: Letter

References (6)

1. R.M. Bramante, M. Rand Angioedema N Engl J Med 365 2011 e4
2. M.R. Bolton, S.L. Dooley-Hash Angiotensin-converting enzyme inhibitor angioedema J Emerg Med 40 2011 e89 e106
3. J.R. Roberts, R. Wuerz Clinical characteristics of angiotensin-converting enzyme inhibitor induced angioedema Ann Emerg Med 20 1991 555
4. J.B. Kostis, H.J. Kim, J. Rusnak, T. Casale, A. Kaplan, J. Corren, E. Levy Incidence and characteristics of angioedema associated with enalapril Arch Intern Med 165 2005 1637
5. United States Food and Drug Administration FDA Drug Safety Communication: Abnormal heart rhythms may be associated with use of Zofran (ondansetron) http://www.fda.gov/Drugs/DrugSafety/ucm271913.htm Accessed December 5, 2011
6. United States Food and Drug Administration FDA Drug Safety Communication: Serious CNS reactions possible when linezolid (Zyvox) is given to patients taking certain psychiatric medications http://www.fda.gov/Drugs/DrugSafety/ ucm265305.htm Accessed December 5, 2011